These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM mBio; 2017 Jul; 8(4):. PubMed ID: 28698273 [TBL] [Abstract][Full Text] [Related]
24. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Umbach JL; Cullen BR Genes Dev; 2009 May; 23(10):1151-64. PubMed ID: 19451215 [TBL] [Abstract][Full Text] [Related]
25. Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease? Naqvi AR; Shango J; Seal A; Shukla D; Nares S Front Immunol; 2018; 9():2099. PubMed ID: 30319604 [TBL] [Abstract][Full Text] [Related]
27. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Gottwein E; Cullen BR Cell Host Microbe; 2008 Jun; 3(6):375-87. PubMed ID: 18541214 [TBL] [Abstract][Full Text] [Related]
28. Viral miRNAs and immune evasion. Boss IW; Renne R Biochim Biophys Acta; 2011; 1809(11-12):708-14. PubMed ID: 21757042 [TBL] [Abstract][Full Text] [Related]
29. Identification and Analysis of Novel Viral and Host Dysregulated MicroRNAs in Variant Pseudorabies Virus-Infected PK15 Cells. Liu F; Zheng H; Tong W; Li GX; Tian Q; Liang C; Li LW; Zheng XC; Tong GZ PLoS One; 2016; 11(3):e0151546. PubMed ID: 26998839 [TBL] [Abstract][Full Text] [Related]
30. miRNAs in the pathogenesis of oncogenic human viruses. Lin Z; Flemington EK Cancer Lett; 2011 Jun; 305(2):186-99. PubMed ID: 20943311 [TBL] [Abstract][Full Text] [Related]
31. Two White Spot Syndrome Virus MicroRNAs Target the Ren Q; Huang X; Cui Y; Sun J; Wang W; Zhang X J Virol; 2017 Apr; 91(8):. PubMed ID: 28179524 [TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus microRNAs. Hook L; Hancock M; Landais I; Grabski R; Britt W; Nelson JA Curr Opin Virol; 2014 Aug; 7():40-6. PubMed ID: 24769092 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA let-7 and viral infections: focus on mechanisms of action. Letafati A; Najafi S; Mottahedi M; Karimzadeh M; Shahini A; Garousi S; Abbasi-Kolli M; Sadri Nahand J; Tamehri Zadeh SS; Hamblin MR; Rahimian N; Taghizadieh M; Mirzaei H Cell Mol Biol Lett; 2022 Feb; 27(1):14. PubMed ID: 35164678 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection. Shen ZZ; Pan X; Miao LF; Ye HQ; Chavanas S; Davrinche C; McVoy M; Luo MH PLoS One; 2014; 9(2):e88531. PubMed ID: 24533100 [TBL] [Abstract][Full Text] [Related]
35. Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. Dölken L; Perot J; Cognat V; Alioua A; John M; Soutschek J; Ruzsics Z; Koszinowski U; Voinnet O; Pfeffer S J Virol; 2007 Dec; 81(24):13771-82. PubMed ID: 17942535 [TBL] [Abstract][Full Text] [Related]
40. The Role of microRNAs in the Viral Infections. Fani M; Zandi M; Rezayi M; Khodadad N; Langari H; Amiri I Curr Pharm Des; 2018; 24(39):4659-4667. PubMed ID: 30636585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]